Fairvalue-Calculator Fairvalue-Calculator
EN DE

Garden Stage Limited (GSIW) Fair Value & Analysis

Financial Services · US · Market cap $49.4M

Price$28.53
Fair Value$3.24
Upside-88.6%
Quality95/100
Evidence: Low Range $2.14 – $4.05

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Garden Stage Limited (GSIW) currently trades at $28.53, while our model-based Fair Value estimate is $3.24 — implying the stock looks roughly 88.6% overvalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Garden Stage Limited, through its subsidiaries, provides financial services in Hong Kong. It offers securities dealing and brokerage services; underwriting and placing services; investment advisory services; due diligence services; introduction and referral services; and asset management services, such as account and fund management services. The company was incorporated in 2022 and is headquartered in Central, Hong Kong. Garden Stage Limited is a subsidiary of Oriental Moon Tree Limited.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Garden Stage Limited (GSIW) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $3.24 versus a price of $28.53 — about −89% (overvalued). Model-based estimate, not financial advice.
What is the fair value of GSIW?
Our 21-model fair value for Garden Stage Limited is $3.24 (as of Jun 26, 2026), built from audited fundamentals. The current price is $28.53.
What is the quality score of GSIW?
Garden Stage Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.